Loading...
Cyclophosphamide eradicates murine immunogenic tumor coding for a non-self-antigen and induces antitumor immunity
Although the majority of cancers respond to chemotherapy, most cancer types relapse, at least in part, due to the poor immunogenicity of most tumor. We have reported before that treatment of tumor bearing mice with a combination of the anti-cancer chemotherapy cyclophosphamide (CTX) and immunotherap...
Saved in:
| Published in: | Int J Immunopathol Pharmacol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
SAGE Publications
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6168726/ https://ncbi.nlm.nih.gov/pubmed/30270681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2058738418796591 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|